Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:12 PM
Ignite Modification Date:
2025-12-26 @ 11:12 PM
NCT ID:
NCT00547612
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically confirmed adenocarcinoma of the pancreas
* Primary or metastatic disease
* At least one site of measurable disease
* Enrolled in an NCI protocol (either a treatment or screening protocol) such as NCI-05-C-0044 or NCI-05-C-0141
PATIENT CHARACTERISTICS:
Inclusion criteria:
* ECOG performance status 0-2
* WBC ≥ 1,200/mm³
* Creatinine \< 2.0 mg/dL
* Negative pregnancy test
* Fertile patients must agree to use effective contraception
* Not pregnant or nursing
Exclusion criteria:
* Allergy to IV contrast
* Claustrophobia that would preclude completion of a scan or unable to lie on one's back for positron emission tomography scan
PRIOR CONCURRENT THERAPY:
Inclusion criteria:
* More than 4 weeks since prior abdominal surgery
Exclusion criteria:
* Prior participation in other research protocols within the past year such that a radiation exposure together with the present study would exceed the annual limits
* Aprepitant within 72 hours of \[18F\]-labeled substance P antagonist receptor quantifier positron emission tomography
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00547612
Study Brief:
Protocol Section:
NCT00547612